HomeCompareTTNP vs BTI

TTNP vs BTI: Dividend Comparison 2026

TTNP yields 85.47% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TTNP wins by $2.07M in total portfolio value
10 years
TTNP
TTNP
● Live price
85.47%
Share price
$2.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.11M
Annual income
$639,398.81
Full TTNP calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — TTNP vs BTI

📍 TTNP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTTNPBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TTNP + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TTNP pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TTNP
Annual income on $10K today (after 15% tax)
$7,264.96/yr
After 10yr DRIP, annual income (after tax)
$543,488.99/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, TTNP beats the other by $541,120.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TTNP + BTI for your $10,000?

TTNP: 50%BTI: 50%
100% BTI50/50100% TTNP
Portfolio after 10yr
$1.07M
Annual income
$321,092.72/yr
Blended yield
29.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

TTNP
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Altman Z
-240.6
Piotroski
1/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TTNP buys
0
BTI buys
0
No recent congressional trades found for TTNP or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTTNPBTI
Forward yield85.47%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$2.11M$37.7K
Annual income after 10y$639,398.81$2,786.64
Total dividends collected$1.85M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: TTNP vs BTI ($10,000, DRIP)

YearTTNP PortfolioTTNP Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$19,247$8,547.01$11,299$598.92+$7.9KTTNP
2$35,969$15,374.24$12,794$703.91+$23.2KTTNP
3$65,338$26,851.55$14,518$829.07+$50.8KTTNP
4$115,497$45,585.62$16,513$978.64+$99.0KTTNP
5$198,892$75,309.60$18,827$1,157.84+$180.1KTTNP
6$334,016$121,202.50$21,518$1,373.12+$312.5KTTNP
7$547,628$190,230.15$24,657$1,632.46+$523.0KTTNP
8$877,445$291,482.95$28,329$1,945.74+$849.1KTTNP
9$1,375,345$436,479.30$32,637$2,325.33+$1.34MTTNP
10$2,111,018$639,398.81$37,708$2,786.64+$2.07MTTNP

TTNP vs BTI: Complete Analysis 2026

TTNPStock

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

Full TTNP Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this TTNP vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TTNP vs SCHDTTNP vs JEPITTNP vs OTTNP vs KOTTNP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.